scorecardresearch
Tuesday, August 5, 2025
TopicModerna

Topic: moderna

Even quarter dose of Moderna’s Covid vaccine induces robust immune response, study says

Researchers from a US institute inoculated 35 people with 25 micrograms of the Moderna vaccine and found antibodies six months after vaccination. Standard dose of vaccines is 100 micrograms.

No need to stop breastfeeding, study tells mothers who have received mRNA Covid shots

Researchers from University of California, San Francisco, however, say this is a preliminary study and needs to be repeated with a bigger population.

Cipla gets DCGI nod to import Moderna’s Covid vaccine for restricted emergency use in India

Permission for restricted emergency use potentially opens up a clear possibility of this vaccine being imported to India in the near future, said NITI Aayog Member Dr V K Paul.

Moderna seeks DCGI nod for its Covid vaccine in India, Cipla applies for import & sale

Moderna has also informed that the US govt has agreed to donate a certain number of doses of the Moderna vaccine through COVAX to India.

Pfizer and Moderna vaccines likely to produce long-lasting immunity, study finds

The study, published in the journal Nature, says most people vaccinated with mRNA vaccines may not need booster shots if the virus & its variants don't evolve much beyond their current forms.

In a first, rare blood clot case linked to Moderna mRNA vaccine reported in US

So far, it was thought that only adenoviral vector-based vaccines — such as the AstraZeneca vaccine — caused rare blood clots.

Moderna vaccine effective in 12-17 year-olds, could become 2nd shot approved for teens in US

Moderna says its vaccine showed 93-100% efficacy in preventing symptomatic Covid in a study of teenagers, and no significant safety concerns were observed.

59% Americans support waiving patents for Covid vaccines and life-saving drugs, survey shows

The poll also revealed that a majority of US voters want pharma giant Moderna to share the technology of its taxpayer-funded vaccine.

Modi govt wants more Covid vaccines, but Moderna is ‘not keen’ & Pfizer has this ‘condition’

CSIR has been in talks with Moderna for around 6 months but the company hasn't shown much interest. Pfizer will reassess Modi govt's latest stance on indemnifying vaccine makers.

On Camera

Where is Skill India money going? It’s a Rs 48,000 crore mystery

All industries are still facing an acute shortage of skilled manpower despite thousands of crores spent on skilling schemes.

BJP MPs go full throttle against Trump even as govt hails enduring India-US ties amid tariff tension

New Delhi: While the Indian government has made a measured response to the 25 percent trade tariff imposed by Donald Trump, many in the BJP...

Trump feared India could arm BrahMos with nuclear warhead to target Pakistan in Op Sindoor—WSJ report

New Delhi: During Operation Sindoor, the United States which had received intelligence suggesting that India had launched BrahMos cruise missiles to strike targets inside...

Pakistan, Dhaka have played Washington well. Back home, Modi ecosystem has an inner conflict

To protect ourselves from Trumpian diplomacy, first we must introspect the bipolarity within our establishment discourse.